Skin Cancer

A special issue of Cancers (ISSN 2072-6694).

Deadline for manuscript submissions: closed (30 November 2012) | Viewed by 15074

Special Issue Editor


E-Mail
Guest Editor
Laboratory of Pathology, National Cancer Institute, Building 10, Room 2S235J, 10 Center Drive, Bethesda, MD 20892, USA
Interests: melanoma; skin cancers; dermatopathology; skin pathology; melanocytic skin lesions
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

Melanoma and non-melanoma skin cancers are the most common form of cancer in the United States and many other countries.  This special issue of Cancers is an opportunity to report orgininal research and discoveries in the field of skin cancer, such as dermatopathology, treatment, epidemiology, and cancer prevention.

Dr. Chyi-Chia Richard Lee
Guest Editor

Keywords

  • skin cancer
  • cutaneous neoplasm
  • squamous cell carcinoma
  • basal cell carcinoma
  • melanoma
  • adnexal tumors
  • dermatopathology
  • skin cancer diagnosis and treatment
  • skin cancer epidemiology and prevention
  • cutaneous tumor biology
  • skin cancer genetics

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Further information on MDPI's Special Issue polices can be found here.

Published Papers (2 papers)

Order results
Result details
Select all
Export citation of selected articles as:

Review

1408 KiB  
Review
The Role of the Immune Response in Merkel Cell Carcinoma
by Pierre L. Triozzi and Anthony P. Fernandez
Cancers 2013, 5(1), 234-254; https://doi.org/10.3390/cancers5010234 - 28 Feb 2013
Cited by 34 | Viewed by 7519
Abstract
Merkel cell carcinoma (MCC) is an aggressive neuroendocrine skin cancer. The Merkel cell polyomavirus (MCPyV) is implicated in its pathogenesis. Immune mechanisms are also implicated. Patients who are immunosuppressed have an increased risk. There is evidence that high intratumoral T-cell counts and immune [...] Read more.
Merkel cell carcinoma (MCC) is an aggressive neuroendocrine skin cancer. The Merkel cell polyomavirus (MCPyV) is implicated in its pathogenesis. Immune mechanisms are also implicated. Patients who are immunosuppressed have an increased risk. There is evidence that high intratumoral T-cell counts and immune transcripts are associated with favorable survival. Spontaneous regressions implicate immune effector mechanisms. Immunogenicity is also supported by observation of autoimmune paraneoplastic syndromes. Case reports suggest that immune modulation, including reduction of immune suppression, can result in tumor regression. The relationships between MCPyV infection, the immune response, and clinical outcome, however, remain poorly understood. Circulating antibodies against MCPyV antigens are present in most individuals. MCPyV-reactive T cells have been detected in both MCC patients and control subjects. High intratumoral T-cell counts are also associated with favorable survival in MCPyV-negative MCC. That the immune system plays a central role in preventing and controlling MCC is supported by several observations. MCCs often develop, however, despite the presence of humoral and cellular immune responses. A better understanding on how MCPyV and MCC evade the immune response will be necessary to develop effective immunotherapies. Full article
(This article belongs to the Special Issue Skin Cancer)
Show Figures

Figure 1

503 KiB  
Review
Mouse Genetic Models Reveal Surprising Functions of IkB Kinase Alpha in Skin Development and Skin Carcinogenesis
by Xiaojun Xia, Eunmi Park, Susan M. Fischer and Yinling Hu
Cancers 2013, 5(1), 170-183; https://doi.org/10.3390/cancers5010170 - 15 Feb 2013
Cited by 5 | Viewed by 6967
Abstract
Gene knockout studies unexpectedly reveal a pivotal role for IkB kinase alpha (IKKa) in mouse embryonic skin development. Skin carcinogenesis experiments show that Ikka heterozygous mice are highly susceptible to chemical carcinogen or ultraviolet B light (UVB) induced benign and malignant skin [...] Read more.
Gene knockout studies unexpectedly reveal a pivotal role for IkB kinase alpha (IKKa) in mouse embryonic skin development. Skin carcinogenesis experiments show that Ikka heterozygous mice are highly susceptible to chemical carcinogen or ultraviolet B light (UVB) induced benign and malignant skin tumors in comparison to wild-type mice. IKKa deletion mediated by keratin 5 (K5).Cre or K15.Cre in keratinocytes induces epidermal hyperplasia and spontaneous skin squamous cell carcinomas (SCCs) in Ikka floxed mice. On the other hand, transgenic mice overexpressing IKKa in the epidermis, under the control of a truncated loricrin promoter or K5 promoter, develop normal skin and show no defects in the formation of the epidermis and other epithelial organs, and the transgenic IKKa represses chemical carcinogen or UVB induced skin carcinogenesis. Moreover, IKKa deletion mediated by a mutation, which generates a stop codon in the Ikka gene, has been reported in a human autosomal recessive lethal syndrome. Downregulated IKKa and Ikka mutations and deletions are found in human skin SCCs. The collective evidence not only highlights the importance of IKKa in skin development, maintaining skin homeostasis, and preventing skin carcinogenesis, but also demonstrates that mouse models are extremely valuable tools for revealing the mechanisms underlying these biological events, leading our studies from bench side to bedside. Full article
(This article belongs to the Special Issue Skin Cancer)
Show Figures

Figure 1

Back to TopTop